Sarepta initiated with a Peer Perform at Wolfe Research

Wolfe Research initiated coverage of Sarepta (SRPT) with a Peer Perform rating.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Yahoo

37 minutes ago

• Yahoo

Wolfe Research Initiates Coverage of BridgeBio Pharma (BBIO) with ‘Outperform' Rating

BridgeBio Pharma, Inc. (NASDAQ:BBIO) is one of the 10 biotech stocks screaming a buy. On June 17, Wolfe Research initiated coverage of the stock with an 'Outperform' rating and a $49 price target. The research firm reiterated the company's solid position amid the 'TTR craze' while also echoing its commercial execution strategy. A medical technician wearing a lab coat operating machinery in a biopharmaceutical laboratory. Consequently, Wolfe Research expects BridegBio's revenue to total $569 million in 2025 before rising to $3.4 billion by 2028. It should peak at $4.4 billion in 2034. For the upcoming second quarter, the research firm expects the company to deliver revenue of $106 million, slightly below market expectation of $111 million. While the stock has shown a remarkable return of 42% year to date, Wolfe Research insists it must navigate several challenges to maintain the positive momentum. It must navigate the potential Vyndaqel loss of exclusivity, achondroplasia data versus competition, and pipeline products. In addition, consistent revenue growth and expanding operating margins will be crucial to the company's long-term success. BridgeBio Pharma, Inc. (NASDAQ:BBIO) is a biopharmaceutical company that develops and delivers transformative medicines for genetic diseases. Its pipeline includes a range of development programs, from early science to advanced clinical trials. While we acknowledge the potential of BBIO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Best Software Stocks to Buy Now and 11 Must-Buy AI Stocks Analysts Are Betting On. Disclosure: None. Sign in to access your portfolio

Business Insider

3 hours ago

• Business Insider

Citi Sticks to Their Hold Rating for New Hope Corporation Limited (NHPEF)

Citi analyst Paul McTaggart maintained a Hold rating on New Hope Corporation Limited (NHPEF – Research Report) yesterday and set a price target of A$3.85. The company's shares closed yesterday at $2.41. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter McTaggart covers the Basic Materials sector, focusing on stocks such as South32, Champion Iron, and Fortescue Metals Group Ltd. According to TipRanks, McTaggart has an average return of 9.1% and a 54.86% success rate on recommended stocks. New Hope Corporation Limited has an analyst consensus of Hold, with a price target consensus of $2.47. The company has a one-year high of $3.90 and a one-year low of $2.00. Currently, New Hope Corporation Limited has an average volume of 1,905.

Business Insider

3 hours ago

• Business Insider

Citi Reaffirms Their Sell Rating on 29metals Ltd. (29M)

Citi analyst Kate McCutcheon maintained a Sell rating on 29metals Ltd. (29M – Research Report) yesterday and set a price target of A$0.15. The company's shares closed yesterday at A$0.25. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, McCutcheon is a 4-star analyst with an average return of 7.6% and a 61.22% success rate. McCutcheon covers the Basic Materials sector, focusing on stocks such as Northern Star Resources Ltd, Evolution Mining , and Mineral Resources Limited. 29metals Ltd. has an analyst consensus of Hold, with a price target consensus of A$0.23. Based on 29metals Ltd.'s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of A$308.04 million and a GAAP net loss of A$68.42 million. In comparison, last year the company earned a revenue of A$209.82 million and had a GAAP net loss of A$133.8 million